Inne is a biotech startup building a hormone-based mini lab for women.
Inne has raised €17M across 2 funding rounds from 7 investors, most recently a Series A round in May 2022. Based in Berlin, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-05-25 | Series A | €9.4M | Borski Fund,Calm Storm Ventures,Dr. Fiona Pathiraja,DSM Venturing,Rolf Schroemgens,Taavet Hinrikus | View deal → |
| 2019-10-01 | Series A | €8.0M | Blossom Capital | View deal → |
